Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

NCT05830084 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma

Interventions

DRUG: regorafenib tablet

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]